MTA-Based Cements: Biocompatibility and Effects on the Gene Expression of Collagen Type 1 and TGF- β 1

Biomed Res Int. 2022 Mar 31:2022:2204698. doi: 10.1155/2022/2204698. eCollection 2022.

Abstract

Objective: This study sought to evaluate the biocompatibility of Neomineral Trioxide Aggregate (Neo-MTA), MTA Repair High Plasticity (MTA-HP), and Mineral Trioxide Aggregate-Angelus white (MTA-Ang) in fibroblasts of human dental pulp.

Materials and methods: Morphology was evaluated after 24 h of incubation. LIVE/DEAD assay and cell adhesion tests were performed at 24 h of treatment. Cell proliferation assays (MTSs) and Annexin V were performed at 48 h incubation with different treatments. The expression of Col-1 and TGF-β1 was tested by endpoint PCR at 5 days of treatment.

Results: Morphological changes were observed in all groups. Neo-MTA and MTA-Ang were associated with increased cell viability, and all materials induced apoptosis, with a higher percentage in the MTA-HP group than in the other groups. In the LIVE/DEAD assay, there was more damage to the cell membrane in the group of cells treated with MTA-HP than in the other groups.

Conclusion: Neo-MTA and MTA-Ang presented similar biocompatibility, and both showed greater biocompatibility than MTA-HP. MTA-HP and MTA-Ang increased Col-1A gene expression, and Neo-MTA and MTA-Ang increased TGF-β1 gene expression in a similar way.

MeSH terms

  • Aluminum Compounds / pharmacology
  • Calcium Compounds / pharmacology
  • Collagen Type I / genetics
  • Drug Combinations
  • Gene Expression
  • Humans
  • Materials Testing
  • Oxides / pharmacology
  • Root Canal Filling Materials* / pharmacology
  • Silicates / pharmacology
  • Transforming Growth Factor beta1* / genetics

Substances

  • Aluminum Compounds
  • Calcium Compounds
  • Collagen Type I
  • Drug Combinations
  • mineral trioxide aggregate
  • Oxides
  • Root Canal Filling Materials
  • Silicates
  • Transforming Growth Factor beta1